Dan Brennan analyst TD COWEN

Currently out of the existing stock ratings of Dan Brennan, 211 are a BUY (69.18%), 89 are a HOLD (29.18%), 5 are a SELL (1.64%).

Dan Brennan

Work Performance Price Targets & Ratings Chart

Analyst Dan Brennan, currently employed at TD COWEN, carries an average stock price target met ratio of 67.6% that have a potential upside of 27.88% achieved within 191 days. Previously, Dan Brennan worked at COWEN.

Dan Brennan’s has documented 641 price targets and ratings displayed on 38 stocks. The coverage is on Healthcare, Basic Materials, Industrials, Communication Services sectors.

Most recent stock forecast was given on ILMN, Illumina at 31-Jul-2026.

Wall Street Analyst Dan Brennan

Analyst best performing recommendations are on TEM (TEMPUS AI, COMMON STOCK).
The best stock recommendation documented was for ILMN (ILLUMINA) at 8/7/2024. The price target of $126 was fulfilled within 1 day with a profit of $4.9 (4.05%) receiving and performance score of 40.46.

Average potential price target upside

BRKR Bruker CRL Charles River Laboratories CTLT Catalent EXAS EXACT Sciences IQV IQVIA Holdings NEO NeoGenomics SLGC Somalogic TMO Thermo Fisher Scientific A Agilent Technologies AVTR Avantor ICLR ICON PLC ILMN Illumina MTD Mettler-Toledo International NVTA Invitae Corp TX Ternium SA ADR WAT Waters DHR Danaher NSTG NanoString Technologies CAI CAI International FLDM Fluidigm GH Guardant Health LAB Standard Biotools MRVI Maravai Lifesciences Holdings  MYGN Myriad Genetics NTRA Natera PACB Pacific Biosciences of California PKI PerkinElmer PPD PPD PSNL Personalis QGEN Qiagen NV QTRX Quanterix Corp RVTY Revvity SYNH Syneos Health TEM Tempus AI, Common Stock TXG 10X Genomics VZ Verizon Communications XGN Exagen ZY Zymergen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 04-Aug-2025

$60

$-2.84 (-4.52%)

$40

Buy Since 21-Jun-2019

$70

$7.16 (11.39%)

$80

Buy Since 19-Dec-2024

$70

$7.16 (11.39%)

$50

Buy Since 06-Nov-2024

$60

$-2.84 (-4.52%)

$53

Hold Since 28-Apr-2020

$43

$-19.84 (-31.57%)

$53

Show more analysts

Please expand the browser size to see the chart

Which stock is Dan Brennan is most bullish on?

Potential upside of $41.02 has been obtained for DHR (DANAHER)

Which stock is Dan Brennan is most reserved on?

Potential downside of -$28.27 has been obtained for TXG (10X GENOMICS)

What Year was the first public recommendation made by Dan Brennan?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?